论文部分内容阅读
随着生活水平的明显提高,饮食结构发生了巨大的变化,人群中高脂血症的发生率呈上升趋势,且呈年轻化,它是心脑血管疾病的重要高危因素。调脂治疗能降低心脑血管疾病的发生率,已得到公认。2004年10月～2006年2月,应用辛伐他汀(商品名舒降之,杭州默沙东制药有限公司生产)治疗高脂血症86例,观察其降脂疗效和不良反应,现总结报告如下。
With the significant improvement of living standards, the diet has undergone tremendous changes. The incidence of hyperlipidemia in the population is on the rise and younger. It is an important risk factor for cardiovascular and cerebrovascular diseases. Lipid-lowering therapy can reduce the incidence of cardiovascular and cerebrovascular diseases, has been recognized. From October 2004 to February 2006, 86 cases of hyperlipidemia were treated with simvastatin (product name Shupan, Hangzhou MSD East Pharmaceutical Co., Ltd.), and the lipid-lowering efficacy and adverse reactions were observed. The summary report is as follows.